- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03461666
Comparison of Efficacy of Behavioral Approaches for Treatment of Insomnia (CEBATI)
A Randomized, Open Label, Sleep Hygiene Controlled 6-Week Study to Compare the Efficacy of Four (CBT-I, FOA, Combined CBT-I and FOA and Sleep Hygiene) Different Behavioral Approaches for the Treatment of Adult Subjects With Insomnia
Study Overview
Status
Conditions
Detailed Description
This study compares the efficacy of four different types (Cognitive Behavior Therapy for Insomnia (CBT-I), Focus of Attention (FOA), Combined CBT-I and FOA and Sleep Hygiene) of therapies approaches for the treatment of insomnia. This study is a randomized, open label study, the participants are asked to review the benefits they get from the intervention. This study involve 6 weekly sessions after screening and completion of the end of treatment, 3-month, 6-month and 12-month follow-up assessment. The trained study staff will administer study scales during therapy session. The subjective review of insomnia improvement will be assessed at end of treatment, 3 months, 6 months and 12 months follow-up assessment. Subjects are adult who meet, DSM-5 the diagnostic criteria for primary Insomnia.
Inclusion/Exclusion criteria to be assessed at Screening (Visit 1) and Visit 2. For those found eligible who complete the study, participation will include Screening (Visit 1), 6 weekly sessions after screening, and completion of the post-treatment and 6-month followup assessment.
Once subject sign the consent form, subject will be asked inclusion and exclusion criteria and will be given details about the study as per protocol.
Those eligible will be randomly assigned to one of four behavioral treatment approaches. The participant will have six weekly one hour in person sessions in which the assigned treatment will be administered. The participant will be assessed at the end of treatment and again at 6 month followup.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Max Hines, Ph.D
- Phone Number: 425-949-5779/ 425-223-2304
- Email: max@pspc.org
Study Contact Backup
- Name: Syed Mustafa, M.D
- Phone Number: 425-806-5021
- Email: sjmustafamd@pspc.org
Study Locations
-
-
Washington
-
Bothell, Washington, United States, 98011
- Puget Sound Psychiatric Center
-
Bothell, Washington, United States, 98011
- Puget Sound Psychiatry Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male and female outpatients who are 18 or older to 72 years. Insomnia Severity Index > or = 10
- Meet diagnostic criteria for Insomnia Disorder per DSM-5 Willing and able to sign Informed consent form Not planning on moving away from the area for the subsequent 12 weeks.
Exclusion Criteria:
- Participants who answer "yes" to any of the following will be excluded:
- Females who are lactating or who are pregnant
- Night shift workers, and individuals who nap 3 or more times per week over the preceding month
- Consumption of caffeine beverages (i.e. tea, coffee, or cola) comprising usually more than 5 cups or glasses per day
- Participation in another trial for insomnia
- Persons unable to complete the study questionnaires and psychological tests
- Persons who are unable to participate for the entire duration of the study, or in the opinion of the investigators, are likely to be non-compliant with the obligations inherent in the trial participation
- Persons self-describing with severe anxiety or severe depression (BDI score of 29 or higher) or severe anxiety (BAI score of 36 or higher).
- Persons with a history of epilepsy, seizures, or dementia
- Any significant, severe or unstable, acute or chronically progressive medical or surgical condition
- Serious head injury or stroke within the past year
- Current alcohol or substance abuse/dependence (must have >90 days of sobriety)
- Presence of other neurological disorders (e.g., multiple sclerosis, Parkinson's Disease)
- Presence of an untreated or unstable medical or psychiatric comorbid condition (e.g., major depressive disorder or psychotic disorder requiring admission within the last two years). People using psychotropic medication, hypnotic or sedative medications may be included if they are on a stable dosage for the last 2 months prior to the study, if the dose remains stable throughout the study, and if the medication is judged to not interfere with the study outcomes.
- Currently on medications known to produce insomnia (e.g., stimulants)
- Sleep apnea (AHI >15) or previous diagnosis of sleep apnea. Study participants who use a continuous positive airway pressure (CPAP) device for sleep apnea will be eligible for participation if they are below the apnea/hypopnea cutoff while using CPAP and agree to use the device during study participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Cognitive Behavior Therapy-Insomnia
Participants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
|
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
|
Active Comparator: Focus Of Attention
Participants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
|
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
|
Active Comparator: Combined-CBT-I and FOA Group
Participants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
|
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
|
Active Comparator: Sleep Hygiene
Participants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
|
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self Report Sleep Measures
Time Frame: through study completion, an average of 1 year
|
SRSM: assess overall quantity of sleep satisfaction on the Self Report Sleep Measures.
|
through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Insomnia Severity Index
Time Frame: through study completion, an average of 1 year
|
ISI: assess the severity of insomnia.
|
through study completion, an average of 1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Max Hines, Ph.D, Puget Sound Psychiatry Center
Publications and helpful links
General Publications
- Becher AK, Hohne M, Axmacher N, Chaieb L, Elger CE, Fell J. Intracranial electroencephalography power and phase synchronization changes during monaural and binaural beat stimulation. Eur J Neurosci. 2015 Jan;41(2):254-63. doi: 10.1111/ejn.12760. Epub 2014 Oct 25.
- Cahn BR, Polich J. Meditation states and traits: EEG, ERP, and neuroimaging studies. Psychol Bull. 2006 Mar;132(2):180-211. doi: 10.1037/0033-2909.132.2.180.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PSPC-17-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Insomnia
-
Midnight Pharma, LLCCompletedChronic Primary InsomniaUnited States
-
IWK Health CentreUnknownPrimary Insomnia | Nonorganic InsomniaCanada
-
Oregon Health and Science UniversityCompletedPrimary Insomnia | Psychophysiological InsomniaUnited States
-
University of RochesterSanofi-SynthelaboCompletedInsomnia | Primary Insomnia | Psychophysiologic InsomniaUnited States
-
US Department of Veterans AffairsCompletedInsomnia | Primary Insomnia | Secondary InsomniaUnited States
-
University of UtahEvans Army Community HospitalCompletedPrimary Insomnia | Secondary InsomniaUnited States
-
University of WashingtonUnknownChronic Insomnia | Insomnia, Primary
-
Jack Edinger, PhDMerck Sharp & Dohme LLCCompletedInsomnia | Primary Insomnia | Chronic InsomniaUnited States
-
University of PittsburghCompletedInsomnia Chronic | Insomnia, PrimaryUnited States
-
Eli Lilly and CompanyCompletedAn Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia (SLUMBER)Primary Insomnia | Secondary InsomniaUnited States
Clinical Trials on Cognitive Behavior Therapy-Insomnia
-
Uppsala UniversityUppsala-Örebro Regional Research CouncilCompleted
-
Johns Hopkins UniversityAmerican Academy of Sleep MedicineCompletedInsomnia | TBIUnited States
-
Walter Reed National Military Medical CenterUniformed Services University of the Health SciencesTerminatedInsomnia | Cardiovascular Risk FactorUnited States
-
Northwestern UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...RecruitingQuality of Life | Inflammation | Sleep Disturbance | Bereavement | SpousesUnited States
-
University of South FloridaRecruitingDementia | Insomnia ChronicUnited States
-
Duke UniversityRecruitingInsomnia | Posttraumatic Stress Disorder | Cardiovascular Risk FactorUnited States
-
Stanford UniversityNot yet recruitingSuicide and Self-harmUnited States
-
University of California, BerkeleyCompletedEveningness/SleepUnited States
-
University of WashingtonKaiser PermanenteUnknown
-
Ohio State University Comprehensive Cancer CenterAmerican Cancer Society, Inc.; Lance Armstrong FoundationCompletedDepression | Pain | Leukemia | Fatigue | Multiple Myeloma | Insomnia | Pancreatic Cancer | Esophageal Cancer | Lung Cancer | Glioblastoma Multiforme | Sleep Disorders | Uncertainty | Ovarian Neoplasm | Anxiety Disorder | Psychological Intervention | Relapsed Lymphoma | Worry | Cognitive-behavioral Therapy | Stage III or IV Cervical... and other conditionsUnited States